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Abstract
Assembly of amyloid-beta peptide (Ab) into cytotoxic oligomeric and fibrillar aggregates is believed to be a major
pathologic event in Alzheimer’s disease (AD) and interfering with Ab aggregation is an important strategy in the
development of novel therapeutic approaches. Prior studies have shown that the double N-methylated analogue of islet
amyloid polypeptide (IAPP) IAPP-GI, which is a conformationally constrained IAPP analogue mimicking a non-amyloidogenic
IAPP conformation, is capable of blocking cytotoxic self-assembly of Ab. Here we investigate the interaction of IAPP-GI with
Ab40 and Ab42 using NMR spectroscopy. The most pronounced NMR chemical shift changes were observed for residues
13–20, while residues 7–9, 15–16 as well as the C-terminal half of Ab - that is both regions of the Ab sequence that are
converted into b-strands in amyloid fibrils - were less accessible to solvent in the presence of IAPP-GI. At the same time,
interaction of IAPP-GI with Ab resulted in a concentration-dependent co-aggregation of Ab and IAPP-GI that was enhanced
for the more aggregation prone Ab42 peptide. On the basis of the reduced toxicity of the Ab peptide in the presence of
IAPP-GI, our data are consistent with the suggestion that IAPP-GI redirects Ab into nontoxic ‘‘off-pathway’’ aggregates.
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Introduction
Protein misfolding and aggregation into amyloid fibrillar aggregates
are associated with a number of severe neurodegenerative diseases
including Alzheimer’s disease (AD) [1]. The main pathological
hallmarks of AD are the extracellular ‘‘senile plaques’’, constituted of
amyloid b (Ab) peptide, and the intracellular ‘‘neurofibrillary tangles’’
of tau protein [2]. Several genetic and pathologic evidences support
the ‘‘amyloid cascade hypothesis’’ of AD, according to which Ab
peptide self-association plays a vital initiating role in AD pathogenesis,
both in familial and sporadic forms of disease [3,4]. Ab peptide
constitutes a small part of a large transmembrane protein, the amyloid
precursor protein (APP), and is released to the extracellular
environment after two consecutive proteolytic cleavages of APP by
b-a n dc-secretase [5]. The 39–42 residue Ab peptide is mostly
unstructured in aqueous solution [6–8], but has a tendency to
undergo a conformational transition to b-sheet aggregates [9]. This
self-association of Ab is known to exert its neurotoxic effects [10].
While the final amyloid fibrillar state of Ab was originally believed to
cause the main toxic effects of this peptide, increasing evidence
suggests that the earliest and most extensive cytotoxic properties of Ab
are mediated by smaller less ordered assemblies of Ab [4,11,12].
Accordingly, Ab aggregation-based strategies to search for AD-
modifying drugs should be targeted to prevent buildup of any toxic
oligomeric species along the assembly reaction.
One approach to inhibit an aggregation reaction is to re-design
the self-recognition interface of peptide or protein molecules, in a
manner that the modified molecule is still capable of interacting
with the native form, but inhibits its further assembly into larger
aggregates [13]. This approach was successfully exploited for
example in the case of Islet Amyloid Polypeptide (IAPP) [13,14].
IAPP is a hydrophobic strongly amyloidogenic peptide, which is
produced in the pancreatic islet cells and plays, in the soluble
monomeric form, a major role in glucose homeostasis [15]. In
certain circumstances, this peptide undergoes a transition from a
predominantly random coil monomeric state to b-sheet aggre-
gates, and these aggregates have been shown to be strongly toxic
for several cell types and associated with the progressive
destruction of pancreatic beta cells in adult-onset diabetes [16].
To keep the physiologic function of IAPP but block its amyloid
forming propensity, an IAPP analogue was designed through the
structure-based introduction of a minimum number of two N-
methyl groups, at Gly24 and Ile26, located in the amyloid core
and with side chains presumably pointing into a similar direction
(see Figure 1A) [13,17]. It was shown that the so-called IAPP-GI
peptide efficiently inhibits IAPP amyloid formation and cytotox-
icity [13,17]. More interestingly, IAPP-GI was demonstrated to
block cytotoxic assembly of Ab and insulin as well [18,19]. The
cross-association reaction between IAPP-GI (or nonfibrillar IAPP
conformers) and Ab may have some implications beyond its
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20289therapeutic potentials, and along with clinical and epidemiological
evidences, provide a potential molecular link between AD and
adult-onset diabetes [20]. On a more general level and based on
recent evidence for other cross-interactions between amyloido-
genic polypeptides and proteins including the Ab-tau and the Ab-
prion protein interaction, it appears that cross-amyloid interac-
tions may play a critical role in neurodegenerative diseases
[21,22].
In the current study, we make use of solution Nuclear Magnetic
Resonance (NMR) measurements to investigate the intermolecular
interaction of Ab with IAPP-GI. Considering the high sequence
similarity of Ab and IAPP-GI and the blockade of Ab aggregation
by IAPP-GI, the results of this study may assist in understanding
the mechanism of the very early steps of Ab self-association into
cytotoxic aggregates and fibrils and its inhibition.
Results and Discussion
Both Ab and IAPP peptides show a remarkable hydrophobicity
in the sequence and a high tendency to self-associate, especially at
concentrations which are normally used in NMR experiments.
Accordingly, Ab-IAPP hetero-association may encounter signifi-
cant kinetic and/or thermodynamic barriers if peptide self-
association is a competing alternative scenario for them.
Therefore, we needed to find an experimental condition under
which these two peptides predominantly populate a monomeric
state. Several studies demonstrate that the full-length Ab40 is
mostly monomeric at neutral pH [8,23], and the peptide does not
significantly change the assembly state if the sample is stored at
concentrations below 100 mM and temperatures as low as 5uC,
provided that the sample is devoid of preformed aggregates [8].
IAPP is also known to be much less prone to aggregation at lower
temperatures [24], and it has been suggested on the basis of
analytical ultracentrifugation and diffusion NMR spectroscopy
that human IAPP is in a kinetically stable state consisting of
monomers and high molecular weight oligomers at neutral pH
and 4uC, even at a concentration as high as 255 mM (1 mg/mL)
[24,25]. However, at temperatures above 20uC, the strong self-
association propensity of human IAPP rapidly drives monomeric
IAPP molecules toward oligo- and multimerization [24–27]. At
this temperature, IAPP-GI has also been shown to self-associate -
similarly to IAPP- with low nanomolar affinity into soluble di- and
oligomers [13]. In contrast to IAPP, however, IAPP-GI oligomers
were found to be unable to further aggregate into cytotoxic
aggregates and amyloid fibrils, due to the conformational
constraint imposed by the two N-methylations [13,17]. Taking
all these points into consideration, we selected as our titration
experimental condition a low temperature of 5uC and a neutral
pH of 7.3 buffered with 20 mM sodium phosphate without
addition of any salt. Ab40, Ab42 - that shows a higher aggregation
propensity than Ab40 and is believed to be the primary toxic
amyloid b peptide [2] - and IAPP-GI in their lyophilized states
were dissolved in 10 mM NaOH and pure HFIP, respectively, as
recommended in references [8,15]. Ab concentrations were kept
constant at 30 mM along the titration experiment, while the IAPP-
GI concentration was varied in the range of 0–480 mM [25].
The 1D
1H-NMR spectra of Ab40 and Ab42 in the absence of
IAPP-GI are characteristic of unfolded peptides, i.e. methyl
resonances are found in two narrow regions of 0.8–1 and 1.3–
1.4 ppm, characteristic for random coil shifts of Val, Leu, Ile and
Ala (Figures 2 and S1). In agreement with the absence of a
threonine residue in the Ab40 as well as Ab42 primary sequence,
no signal was observed at around 1.1 ppm. After addition of IAPP-
GI, the overall signal intensity was increased, and some new
signals appeared, e.g. there were two new signals at around 1.1
and 1.2 ppm, i.e. close to the random coil chemical shift of the
methyl group of Thr residues, and therefore probably originate
from the four Thr residues of IAPP-GI. In addition, NMR signals
were observed at 6.82, 7.00 and 7.35 ppm exclusively in the
presence of IAPP-GI (Figures 2 and S1). The intensities of the
Figure 1. Primary structures of Ab, IAPP and IAPP-GI (A) and tautomeric and protonation states of histidine side chain (B).
1H-
15N
HSQC spectra of histidine side chains were acquired with coherence transfer from e1H and d2H to e2N and d1N through
2J coupling constants.
doi:10.1371/journal.pone.0020289.g001
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concentration for the NMR-visible IAPP-GI molecules during the
titration. In case of Ab40, the IAPP-GI specific signals increased in
intensity by factors of 2.1, 3.6 and 6.8 in the spectra with 4, 8 and
16 molar excess of IAPP-GI when compared to the spectrum with
two-fold excess of IAPP-GI. The slower rise in the peak intensity
than expected on the basis of the added amount of IAPP-GI
suggests that IAPP-GI partially aggregates to large NMR-invisible
states during the titration. In case of Ab42, the relative intensity of
the IAPP-GI specific NMR signals increased even less with
increasing IAPP-GI concentration, suggesting that the Ab peptide
and its specific aggregation propensity plays a role in aggregation
of IAPP-GI (Figure S1). The formation of aggregates during the
titration is further supported by the emergence of an additional,
relatively broad signal at around 0.7 ppm (marked with *), which
appeared at a IAPP-GI:Ab40 ratio of 4:1 and became stronger at
the ratio of 16:1. In case of Ab42, this broad peak is already
present at a IAPP-GI:Ab42 ratio of 1:1. The new NMR signal may
Figure 2. 1D
1H NMR spectra of Ab40 with or without IAPP-GI. The aliphatic and amide regions of the spectra are shown in (A) and (B),
respectively. The spectra were measured in the presence of 0 (black), 2 (red), 4 (orange), 8 (green) and 16 (blue) molar excess of IAPP-GI. Chemical
shifts were calibrated on the basis of an external DSS reference and temperature was 5uC. Note the peak at 0.7 ppm, marked as *, which is probably
related to an oligomeric state of IAPP-GI or Ab40. Peaks at 1.15, 6.82, 7.00 and 7.35 ppm are exclusively observed after addition of IAPP-GI.
doi:10.1371/journal.pone.0020289.g002
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the monomeric state, as suggested for IAPP at low temperatures
[25], or alternatively be caused by an oligomeric state of Ab, now
induced by a high concentration of IAPP-GI [28].
To obtain site-resolved information about the interaction of Ab
with IAPP-GI, a series of two-dimensional
1H-
15N HSQC
measurements were performed for 30 mMo f
15N-labeled Ab40
and Ab42 at increasing concentrations of IAPP-GI. Increasing
concentrations of IAPP-GI resulted in a uniform reduction of
signal intensities of Ab40 and Ab42: the average intensity ratio of
the backbone signals of Ab42 was 0.57(60.02) for the last titration
point when compared to the first one (Figures 3A and S2). In
addition, the side-chain signals of Arg5, Gln15 and Asn27 obeyed
a similar trend of decreasing intensity. The uniform loss of NMR
signal intensities in the backbone and side chains upon increasing
IAPP-GI concentrations suggests that IAPP-GI induces aggrega-
tion of Ab42 into large oligomeric NMR-invisible states. The
bigger loss of Ab42 intensity when compared to Ab40 (43 percent
vs 16 percent at the same IAPP-GI/Ab ratio) is consistent with the
higher aggregation propensity of Ab42 compared to Ab40.
Together with the aggregation of IAPP-GI in the presence of
Ab described above (Figures 2 and S1), our data reveal a
concentration-dependent co-aggregation of Ab and IAPP-GI that
is enhanced for the more aggregation prone Ab42 peptide.
Besides the uniform decrease in NMR signal intensity, several
residues showed small changes in their N and H
N chemical shifts
after addition of IAPP-GI, while no significant chemical shift
perturbation was found in the control experiments (Figure 3B).
The strongest chemical shift changes were observed in a stretch of
the peptide extending from His13 to Phe20, with additional
perturbations appearing at residues Arg5, Ser8 and Asp23
(Figure 4A). Moreover, chemical shift changes of most of the
peaks followed a linear relationship up to a molar ratio of IAPP-
GI:Ab40 of 16:1, with the largest linear slopes observed for
residues His13-Lys16 (Figure 4B). Similar chemical shift changes
were observed upon addition of IAPP-GI to Ab42 (Figure 5). The
gradual change in chemical shifts, the absence of new peaks and
the lack of any site-specific broadening effect during the titration,
suggests that the interaction between the two peptides occurs in
the fast exchange regime on the NMR time scale and that the
affinity of IAPP-GI to bind Ab is relatively weak at the conditions
of the NMR experiment.
At first sight, the low affinity between Ab and IAPP-GI observed
in the NMR experiments appears to be in contrast with the
previously reported affinity of their interaction as derived from
fluorescence titration assays [18]. In these studies, N-terminal
fluorescein labeled IAPP-GI (Fluos-IAPP-GI) (1 nM) was titrated
with Ab40 using low nano- to submicromolar Ab40 concentra-
tions and an app. Kd of 50 nM was determined [18]. Our current
results together with those of previous studies suggest, however,
that the differences in apparent affinities are due to different
peptide assembly states - regarding both Ab40 and IAPP-GI -
present in the NMR titration studies as compared to the
fluorescence titration assay [18]. Indeed, at the micromolar
peptide concentrations used in the NMR titration study, two
oligomeric Ab40 species of ,30 and ,150 nm in hydrodynamic
radius were observed using dynamic light scattering (Figure S3 and
Methods S1), despite using NaOH to dissolve pre-formed Ab40
aggregates [8]. Addition of IAPP-GI led then to further
aggregation of Ab40 as shown above. Similar to Ab40, IAPP-GI
populates an aggregate state in equilibrium with the monomeric
state, with a shift toward aggregation occurring at higher IAPP-GI
concentrations [26]. In fact, the high self-assembly propensity of
IAPP-GI into soluble but -in contrast to IAPP- nonamyloidogenic
dimers and oligomers, with self-assembly starting already in the
low nanomolar concentration range, has been earlier demonstrat-
ed using various biophysical methods [13]. These included
fluorescence spectroscopy, i.e. titration of Fluos-IAPP-GI (1 nM)
with IAPP-GI (app. Kd, 4 nM) [13], transmission electron
microscopy [13], CD concentration dependence studies ([13],
see also Figure S4 and Methods S1), size exclusion chromatog-
raphy [13], and SDS-PAGE and Western blot analysis of cross-
linked IAPP-GI samples [18]. Based on the above data, it becomes
Figure 3. Probing the binding of IAPP-GI to Ab using NMR
spectroscopy. A. Variation of
1H-
15N-HSQC peak intensity of Ab40 or
Ab42 upon titration with un-labeled IAPP-GI. Intensity ratios were
calculated relative to intensities of free Ab spectra, and error bars
represent variation along the sequence. Note that loss of signal
intensity is more enhanced for Ab42 than Ab40. B.
1H-
15N-HSQC spectra
of Ab40 in the absence (green) or presence of 16 molar excess of non-
labeled IAPP-GI (red). A shift in the position of His13, His14, Gln15, Lys16
and Leu17 peaks is evident.
doi:10.1371/journal.pone.0020289.g003
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measured using fluorescence spectroscopy was determined under
conditions where IAPP-GI is mainly in a monomeric state [13]
and Ab40 mainly in a monomer or dimer state (submicromolar
concentrations), the interaction followed in our NMR study here
included at least in a large part interactions between (NMR-visible)
Ab monomers and IAPP-GI oligomeric assemblies. Therefore, the
actual monomeric concentrations of Ab and IAPP-GI under the
NMR conditions were considerably less than the nominal peptide
concentrations, and the apparent affinities observed here using
NMR are not comparable with those of fluorescence titration
assays obtained at nanomolar concentrations of Ab40 and IAPP-
GI. In addition, as both IAPP-GI and Ab40 (or Ab42) have been
recently shown to use the same regions in their self- and hetero-
association processes, a reduced affinity between interactions of
their oligomeric states would be expected which is consistent with
the NMR observations [38]. At the same time, however, a strong
inhibitory effect of IAPP-GI on Ab40 and Ab42 fibrillogenesis and
cytotoxicity has been shown using assay systems containing low
micromolar concentrations of Ab and IAPP-GI [18,38], suggesting
Figure 4. NMR chemical shift perturbation in Ab40 upon addition of IAPP-GI. A. Average backbone N and H
N chemical shift difference of
Ab40 after addition of a 16 fold molar excess of IAPP-GI. B. Slope of the best fitted line to chemical shift perturbation vs IAPP-GI concentration data,
presented in units of ppm/M.
doi:10.1371/journal.pone.0020289.g004
Figure 5. Average backbone N and H
N chemical shift pertur-
bation in Ab42 upon addition of IAPP-GI. The values are reported
as slope of the best fitted line to chemical shift difference vs IAPP-GI
concentration data, in units of ppm/M.
doi:10.1371/journal.pone.0020289.g005
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mechanism of IAPP-GI on Ab. To obtain more direct evidence for
the effect of IAPP-GI oligomerization on its binding affinity to
Ab40, we titrated synthetic N-terminal fluorescein labeled Ab40
(Fluos-Ab40) (1 nM) with increasing amounts of IAPP-GI (Figure
S5 and Methods S1). Binding of IAPP-GI to Fluos-Ab40 resulted
in a strong increase of the fluorescence emission. A sigmoidal
binding isotherm was obtained with a plateau at an IAPP-GI
concentration between 250–500 nM and curve fitting yielded an
app. Kd of 39 nM for the Fluos-Ab40-IAPP-GI interaction of
39 nM (Figure S5A). The obtained Kd was nearly identical to the
app. Kd of 41.2 nM (63.9) which was obtained by titrating Fluos-
IAPP-GI (1 nM) with Ab40 confirming thus this previously
reported high affinity of interaction between the two peptides
[18]. However, titrating Fluos-Ab40 with IAPP-GI using IAPP-GI
concentrations higher than 500 nM, i.e. between 1–10 mM,
resulted in a dramatic decrease of the fluorescence emission
determined at the plateau of the Fluos-Ab40-IAPP-GI mixture
(Figure S5B). These findings were consistent with the suggestions
(a) that significant amounts of different IAPP-GI oligomeric
assemblies are populated at concentrations higher than 1 mMa s
compared to the species present between 1 and 500 nM and (b)
that formation of the above IAPP-GI oligomers likely depletes
from the solution large amounts of the IAPP-GI species which are
able to bind Ab40 with low nanomolar affinity.
To obtain further insights into the contribution of His13 and
His14 for binding to IAPP-GI, side chain
1H-
15N HSQC spectra
in the free and IAPP-GI-interacting forms of Ab40 were
compared. The chemical shifts of the e2 and d1 nitrogens of the
imidazole ring of histidine residues and their pattern of coupling to
carbon-attached e1 and d2 protons are sensitive probes of their
protonation, tautomeric and hydrogen bonding states [29]. As
depicted in Figure 6, peaks of all three histidine side chains
(including His6, which is not present in the backbone spectra)
could be observed, and two of them, probably the consecutive
His13 and His14, have very similar chemical shifts of e2N, d1N
and e1H. There is a large dispersion in the nitrogen dimension,
indicating that the imidazole ring should be in an amphionic (non-
protonated) state. This is consistent with the pH 7.3 of our sample,
which is around one unit above the expected pKa of histidines.
The chemical shifts of the e2 and d1 nitrogens are in the range of
177–180 and 218–220 ppm, respectively, suggesting that they may
be involved in some form of H-bonds [30]. The observed pattern
of coupling of
15N nuclei to
1H denote that the histidine side
chains are largely populated in a tautomeric state in which e2N is
attached to a proton, and the weak intensity of the d2H-d1N peak
suggest a small but still detectable
3J coupling between them [31].
After addition of IAPP-GI, the large dispersion in
15N dimension
and the characteristic pattern of coupling between
15N and
1H
nuclei remained unchanged. However, the following changes were
observed: first, while all three e2N chemical shifts were changed by
a similar value of 0.8 ppm toward downfield, d1N chemical shifts
were affected more strongly and not in a uniform manner. The
perturbation of the d1N chemical shift was 4.7 and 6.5 ppm for
two histidines and around 10 ppm for the third one, which is also
severely broadened. Secondly, all the peaks experienced a
significant degree of broadening upon addition of IAPP-GI. The
intensity ratio for the e2N correlations was between 20 and 30%
for all the histidines of Ab40. In contrast, for the d1N correlations,
it was 28 percent for one and only about 7 percent for the other
two. Third, the weak
3J-based d1N-d2H peaks completely
disappeared after addition of IAPP-GI. The direction of chemical
shift deviation can be taken to suggest that, after interaction with
IAPP-GI, d1N of His13 and His14 spends more time in the
protonated state and/or by average, has a smaller degree of
solvent exposure [30]. The change in the protonation state cannot
be caused by a variation of the sample pH, as the pH was
accurately adjusted after addition of IAPP-GI. Instead, it is likely
to originate from a change in the pKa of the histidines caused by
binding-induced changes in the micro-environment. The signifi-
cant broadening of the d1N correlations might be attributed to a
fast/intermediate exchange of Ab40 between free and bound
forms. To further investigate if these changes are caused by
intermolecular interactions between Ab40 and IAPP-GI, we
measured the same spectra for the more aggregation-prone
Ab42. As displayed in Figure 6B, pure Ab42 showed a pattern
that is very similar to that of Ab40 with IAPP-GI, further
Figure 6. Influence of IAPP-GI binding on the protonation and
tautomeric states of the histidines. A. Side chain
1H-
15N-HSQC
spectra of Ab40, in the absence (green) and presence (red) of IAPP-GI.
Magnetization was transferred through an INEPT-based coherence
transfer from e1 and d2 protons of histidine side chains to e2 and d1
nitrogen nuclei (see Figure 1B). The total duration of the INEPT was set
to 27.8 ms. B. Comparison of side chain
1H-
15N-HSQC spectra of Ab40
(green) and Ab42 (red). The cross-peak pattern of all the three histidine
residues of Ab (His6, His13 and His14) was observed.
doi:10.1371/journal.pone.0020289.g006
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intermolecular interactions between Ab and IAPP-GI.
Next, we measured sequence specific water-amide proton
exchange rates for Ab40 in the absence and presence of IAPP-
GI using CLEANEX-PM-FHSQC experiments [32]. The water-
amide proton exchange rate is a valuable probe of the degree of
exposure of the protein backbone to the solvent: a N-H group that
is buried inside the protein or involved in a hydrogen bond, will be
protected from exchange with solvent. In a CLEANEX-PM-
FHSQC experiment, exposed parts of the backbone gain high
signal intensity already at short mixing times due to efficient
exchange with water, while for more protected groups the signal
intensity only rises at longer mixing times. In the absence of IAPP-
GI, Gly25, Ser26, Asn27, Lys28 and Gly29 of Ab40 showed a
strong increase in NMR signal intensity already at a mixing time
of 100 ms (Figure 7). The solvent exposure of these residues was
further corroborated by analysis of the initial exchange rate
(Figure 8A): the highest exchange rates were observed for residues
Ser8-Gly9, His14, Lys16, Asp23, Gly25–Gly29 and Gly37–Gly38.
Interestingly, Gln15-Val24 and Ala30-Val36 have a high tendency
to adopt a-helical [33] or b-strand [34] secondary structures, while
the intervening region of Val24-Gly29 tends to form a loop [35].
Additionally, solid-state NMR studies of Ab fibrils have verified
that the region between residues 23 and 29 forms an exposed turn-
like structure between two b-strands [36,37]. Altogether, the
observed profile of exchange rates suggests that the monomeric
free form of Ab40 transiently samples conformational states, in
which residues 10–13, 17–22 and 30–36 are partially protected
from exchange with solvent. Addition of IAPP-GI results in a
decrease of the exchange rate of residues Asp7, Gly9, Gln15 and
Lys16, as well as Val24–Val36 (Figure 8B). The reduced exchange
rates suggest that these residues are less exposed to the solvent after
IAPP-GI addition. Increased protection could be a result of
an intermolecular interaction between IAPP-GI and Ab40, or
Figure 7. Probing the water-amide proton exchange rates through a CLEANEX-PM-FHSQC experiment. A.
1H-
15N-FHSQC spectrum of
free Ab40. The peak intensities of the
1H-
15N-FHSQC spectrum were used as reference to calculate the relative intensity of peaks due to chemical
exchange. B. CLEANEX-PM-FHSQC spectrum, measured after a selective excitation of water protons and a following 100 ms mixing time during which
chemical exchange between water and amide protons occurred variably for different residues of Ab40.
doi:10.1371/journal.pone.0020289.g007
Interaction of IAPP-GI with Amyloid Beta Peptide
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20289alternatively caused by an IAPP-GI induced change in the
conformation or assembly state of Ab40. Support for the influence
of intermolecular interactions comes from a comparison of
exchange rates in Ab40 and Ab42. In Ab42, which has a higher
tendency for self-association, the exchange rates are reduced in
regions (Figure 9) that are also affected upon addition of IAPP-GI
to Ab40 (Figure 8B).
A recent analysis of the Ab-IAPP and Ab-IAPP-GI interaction
interface using synthetic peptides and peptide arrays has shown
that the ‘‘hot spot regions’’ of the Ab-IAPP and Ab-IAPP-GI
interfaces are localized predominantly within the two regions
which are converted into b-strands in amyloid fibrils [38]. These
studies have also suggested that the hydrophobic C-terminal part
of Ab (residues 29–40) binds IAPP (and IAPP-GI) with a 10-fold
higher affinity as compared to the N-terminal part (residues 1–28),
which binds IAPP with low mM affinity [38], and that the region
between Phe19 and Glu22 was the shortest residue stretch in the
N-terminal part of Ab required for low mM binding, while no
evidence for a direct interaction of the Ab region between His13
and Leu17 was observed [38]. Our NMR chemical shift
perturbation data assign now an important role in the Ab-
IAPP-GI interaction to residues His13 to Leu17, the region of Ab
that is important for binding to ganglioside micelles [39]. At the
same time, the water-amide proton exchange data of Ab40 in the
absence and presence of IAPP-GI suggest that in addition to the
N-terminal region, residues in the C-terminal part are also
involved in the interaction. Taking all these findings into
consideration, we propose the following model for the Ab40-
IAPP-GI interaction: The C-terminal part of Ab is directly
involved in intermolecular interaction with IAPP-GI. This
intermolecular interaction induces a conformational change in
the N-terminal part of Ab, which is favored by the high propensity
of the N-terminal region of Ab40 to assume secondary structure
[33,34]. The conformational transition then leads to changes in
pKa and protonation state of the histidine residues. Since the
IAPP-GI peptide has a high degree of sequence similarity to Ab,
the Ab-IAPP-GI interaction might represent some of the initial
steps in self-association of Ab molecules. In fact, the proposed
model for interaction between Ab and IAPP-GI has some
similarities with a recently published structure of Ab oligomers,
where the N- and C-terminal parts of Ab are involved in intra-
and inter-molecular interactions, respectively [40].
Figure 8. Initial water-amide proton exchange rates (k). A. Exchange rate, k, along the sequence of Ab40 in the free form, measured through a
CLEANEX-PM-FHSQC experiment. B. The change in exchange rate of Ab40 residues after addition of a 16-molar excess of IAPP-GI. Residue numbers
are indicated.
doi:10.1371/journal.pone.0020289.g008
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1H-
15N
HSQC spectra of Ab40 and Ab42 upon increasing concentrations
of IAPP-GI points to a IAPP-GI dependent conversion of Ab to an
NMR-invisible state, i.e. a large and/or non-homogeneous
aggregate state with slow tumbling and/or significant inhomoge-
neity that broaden its signals beyond experimental detection level.
Because the NMR-visible signals of IAPP-GI are reduced at the
same time, it is most likely that aggregates are formed that
comprise both Ab and IAPP-GI [18]. In agreement with their
intrinsic aggregation propensities, the aggregation is more evident
in the case of Ab42 than Ab40. As it has previously been shown
that IAPP-GI significantly lowers Ab-mediated toxicity when both
are mixed in micromolar concentrations, i.e. similar to the
conditions used in the current study, our data suggests that the
aggregate state of Ab induced in the presence of IAPP-GI is not a
toxic ‘‘on-pathway’’ aggregate, but a nontoxic ‘‘off-pathway’’
aggregate which is consistent with previous findings [18]. A similar
redirection of Ab and a-synuclein into off-pathway oligomers was
previously reported for the polyphenol (-)-epigallocatechin gallate
[41], suggesting a similar toxicity lowering mechanism of IAPP-GI
and (-)-epigallocatechin gallate, at least at high inhibitor/peptide
concentrations. Finally, our studies provide evidence that the
interaction between Ab and IAPP-GI leads to a conformational
change in the region Ab (13–17) that might be related to the
inhibitory effect of IAPP-GI on Ab ‘‘on-pathway’’ aggregation and
cell toxicity.
Materials and Methods
Materials
15N-uniformyl labeled Ab1-40 and Ab1-42 was purchased
from rPeptide, and dissolved in 10 mM NaOH solution at 2 mg/
mL concentration [8]. Synthetic IAPP-GI was synthesized as
previously described [13] and dissolved in pure 1,1,1,3,3,3,-
hexafluoroisopropanol (HFIP) at a concentration of 5 mg/mL.
N-terminal fluorescein labeled Ab40 was prepared as described
for the labeled IAPP segments [38]. HFIP was obtained from
Fluka. Before titration experiments, the solvent (HFIP) was
evaporated under N2 gas and phosphate buffer was used to
dissolve dried IAPP-GI.
NMR Spectroscopy
All NMR spectra were recorded at 278 K with a sample of
30 mM
15N-uniformly labeled Ab40 or Ab42, with or without the
specified concentration of non-labeled IAPP-GI, in 20 mM
sodium phosphate buffer at pH 7.3 (adjusted after adding
peptides). Chemical shift referencing at this temperature was
made with respect to the external 4,4-dimethyl-4-silapentane-1-
sulfonic acid (0.0 ppm). All NMR spectra were processed and
analyzed with NMRPipe and Sparky.
The interaction of IAPP-GI with Ab40 and Ab42 was assessed
through a series of
1H-
15N HSQC spectra of Ab in the presence of
0, 2, 4, 8 and 16 molar excess of IAPP-GI for Ab40 and 0, 1, 2, 4
and 8 molar excess of IAPP-GI for Ab42. Titrations were made on
the same peptide sample, and temporal stability of peptide
solutions were checked with 1D
1H-NMR spectra measured
before and after each NMR experiment. The spectra were
measured on a Bruker Avance 600 MHz spectrometer equipped
with a triple-resonance room temperature probe. The time
domain data contained 1 K and 220 complex data points in t2
and t1, respectively. The 90u-shifted squared sine bell function was
used as apodization function in both dimensions, yielding a final
matrix of 8K*512 data points. The peak assignments were
obtained from the literature, and their deviation from the original
position was monitored as a function of IAPP-GI/Ab molar ratio.
The average chemical shift deviation was calculated as the root
square of (DN/5)‘2+(DH)‘2, where DN and DH were the chemical
shift difference of N and H
N resonances compared to the control
experiment. The first (IAPP-GI:Ab ratio of 0) and last (IAPP-
GI:Ab ratio of 16) experiments were re-measured on the higher
field Bruker AMX 800 MHz, equipped with a cryogenic probe to
confirm the observed chemical shift perturbations. In a control
experiment, Ab40 was similarly titrated with phosphate buffer
after dissolving the dried HFIP (without IAPP-GI) under N2 gas.
1H-
15N HSQC spectra of the side chains of histidines (H6, H13
and H14) were acquired on a Bruker AMX 600 MHz spectrom-
eter equipped with a triple-resonance cryogenic probe. The
sample was 30 mMA b40, with or without a 16 molar excess of
IAPP-GI. A 30 mM sample of Ab42 was also measured. The
INEPT transfer delay was selected as 27.8 ms, to obtain the
coherence transfer from the e1H and d2H protons to the e2N and
Figure 9. Difference between the initial water-amide proton exchange rates of Ab42 and Ab40 (Dk=Ab422Ab40). The initial exchange
rates were measured through a CLEANEX-PM-FHSQC experiment. Most residues show less solvent exposure in Ab42 than Ab40.
doi:10.1371/journal.pone.0020289.g009
Interaction of IAPP-GI with Amyloid Beta Peptide
PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e20289d1N through the
2J coupling constant (Figure 1B). The carrier and
SWH values were 5.00 ppm and 6010 Hz in the direct dimension,
and 185.31 ppm and 9728 Hz in the indirect dimension. The
experimental matrix was 2K*256 complex data points, which after
apodization through a 90u-shifted squared sine bell function in
both dimensions was transformed to a final matrix of 8K*512 data
points.
The solvent accessibility of the Ab40 backbone in the free and
possibly IAPP-GI-bound forms was evaluated through measure-
ment of exchange rates between water and NH protons. To this
end, CLEANEX-PM-FHSQC experiments were recorded on a
Bruker Avance 600 MHz spectrometer equipped with a triple-
resonance room temperature probe. In a CLEANEX-PM-
FHSQC experiment, a selective water excitation is followed by a
mixing time (tm) of durations 4, 8, 16, 24, 32, 48, 75, 100, 200 and
500 ms, during which chemical exchange between water and NH
protons takes place. The intensity of peaks as a function of mixing
time was fitted to the following equation:
V=V0~k: exp {R1B:tm ðÞ {exp { R1Azk ðÞ :tm ½  fg =
(R1Azk{R1B)
ð1Þ
where V0 is the intensity of the peak in a control FHSQC
experiment, k is the normalized rate constant related to the
forward exchange rate constant between water and NH protons,
and R1A and R1B are apparent longitudinal relaxation rates for
protein and water [32].
Supporting Information
Figure S1 1D
1H NMR spectra of Ab42 with or without
IAPP-GI. The methyl and aromatic regions of the spectra are
shown in (A) and (B), respectively. The spectra were measured in
the presence of 0 (black), 1 (red), 2 (orange), 4 (green) and 8 (blue)
molar excess of IAPP-GI. Chemical shifts were calibrated on the
basis of an external DSS reference and the temperature was set to
5uC. Peaks marked as * are observed exclusively after addition of
IAPP-GI, and their relative intensities are taken to follow the rise
of NMR-visible IAPP-GI concentration.
(EPS)
Figure S2 Loss of the peak intensities in
1H-
15N-HSQC
spectra of
15N-labeled Ab42 upon addition of non-labeled
IAPP-GI. IAPP-GI/Ab42 molar ratios varied between 0, 1, 2, 4
and 8, as indicated. The intensity ratios were calculated relative to
the intensities of free Ab42 spectrum.
(EPS)
Figure S3 Dynamic light scattering of Ab40. In addition to
a small monomeric peak around 1.6 nm, two oligomeric peaks are
observed at around 30 and 150 nm. Note that the intensity of the
peaks does not reflect the relative amount of each species, as large
species scatter light more intensely than the small NMR-visible
monomeric species at 1.6 nm.
(EPS)
Figure S4 Far-UV CD concentration dependence study
of the conformation of IAPP-GI. CD spectra of IAPP-GI were
measured in aqueous buffer, pH 7.4 (1% HFIP), at peptide
concentrations between 500 nM and 50 mM, as indicated.
(EPS)
Figure S5 Ab40-IAPP-GI interaction as determined by
fluorescence spectroscopy. N-terminal fluorescein labelled
Ab40 (Fluos-Ab40) (1 nM) was titrated with increasing amounts of
IAPP-GI as indicated. (A) The binding curve of Fluos-Ab40-IAPP-
GI interaction obtained using concentrations of IAPP-GI between
1–500 nM is shown (fluorescence emission at 522 nm). (B) The
fluorescence emissions at 522 nm of the different mixtures of
Fluos-Ab40 with IAPP-GI made using concentrations of IAPP-GI
between 1 nM and 10 mM are shown. Fluorescence of Fluos-Ab40
alone was subtracted.
(EPS)
Methods S1 Dynamic Light Scattering.
(DOC)
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